nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A disease-modifying approach to the treatment of IgA nephropathy targeting mucosal IgA synthesis and beyond
|
Coppo, Rosanna |
|
|
103 |
2 |
p. 258-261 |
artikel |
2 |
Anomalous kinetics of galactose-deficient IgA incurring nephropathy revealed by cross-scale optical imaging
|
Si, Meijun |
|
|
103 |
2 |
p. 320-330 |
artikel |
3 |
A polygenic score for reduced kidney function and adverse outcomes in a cohort with chronic kidney disease
|
Steinbrenner, Inga |
|
|
103 |
2 |
p. 421-424 |
artikel |
4 |
CD248 induces a maladaptive unfolded protein response in diabetic kidney disease
|
Krishnan, Shruthi |
|
|
103 |
2 |
p. 304-319 |
artikel |
5 |
Complementary medicine and phospholipase A2 receptor (PLA2R)–related membranous nephropathy—fortuitous or causal?
|
Kaur, Prabhjot |
|
|
103 |
2 |
p. 425-427 |
artikel |
6 |
Corrigendum to “Novel retinal vascular phenotypes for the potential assessment of long-term risk in living kidney donors.” Kidney Int. 2022;102:661–665
|
Giarratano, Ylenia |
|
|
103 |
2 |
p. 429-430 |
artikel |
7 |
Corrigendum to “Ttc21b deficiency attenuates autosomal dominant polycystic kidney disease in a kidney tubular- and maturation-dependent manner.” Kidney Int. 2022;102:577–591
|
Wang, Wei |
|
|
103 |
2 |
p. 429 |
artikel |
8 |
Does kidney transplant improve health-related quality of life for youth with chronic kidney disease?
|
Johnson, Rebecca J. |
|
|
103 |
2 |
p. 256-258 |
artikel |
9 |
Editorial Board
|
|
|
|
103 |
2 |
p. A1 |
artikel |
10 |
Effects of aspirin on cardiovascular outcomes in patients with chronic kidney disease
|
Mann, Johannes F.E. |
|
|
103 |
2 |
p. 403-410 |
artikel |
11 |
Erdheim-Chester disease: hairy kidney and coated aorta
|
Ritter, Alexander |
|
|
103 |
2 |
p. 431 |
artikel |
12 |
Estimating the prevalence of chronic kidney disease while accounting for nonrandom testing with inverse probability weighting
|
Mazhar, Faizan |
|
|
103 |
2 |
p. 416-420 |
artikel |
13 |
False-positive anti-PLA2R ELISA testing in patients with diabetes mellitus
|
Caza, Tiffany N. |
|
|
103 |
2 |
p. 425 |
artikel |
14 |
False positivity for PLA2R1 antibody measured by ELISA in a nephrotic patient with no membranous nephropathy
|
Hoxha, Elion |
|
|
103 |
2 |
p. 411-415 |
artikel |
15 |
Glomerular diseases in pregnancy: pragmatic recommendations for clinical management
|
Fakhouri, Fadi |
|
|
103 |
2 |
p. 264-281 |
artikel |
16 |
Good and evil, more reasons to study UPR
|
Inagi, Reiko |
|
|
103 |
2 |
p. 254-256 |
artikel |
17 |
Hematopoietic-specific melanocortin 1 receptor signaling protects against nephrotoxic serum nephritis and mediates the beneficial effect of melanocortin therapy
|
Guan, Xuejing |
|
|
103 |
2 |
p. 331-342 |
artikel |
18 |
In memoriam: Rashad Sami Barsoum
|
Naicker, Saraladevi |
|
|
103 |
2 |
p. 236-238 |
artikel |
19 |
in this issue
|
|
|
|
103 |
2 |
p. 235 |
artikel |
20 |
Journal Club
|
|
|
|
103 |
2 |
p. 243-245 |
artikel |
21 |
Kidney injury and congenital solitary functioning kidney: more research efforts are needed
|
Marzuillo, Pierluigi |
|
|
103 |
2 |
p. 427-428 |
artikel |
22 |
Longitudinal assessment of the health-related quality of life of children and adolescents with chronic kidney disease
|
Guha, Chandana |
|
|
103 |
2 |
p. 357-364 |
artikel |
23 |
Podocyte expression of human phospholipase A2 receptor 1 causes immune-mediated membranous nephropathy in mice
|
Tomas, Nicola M. |
|
|
103 |
2 |
p. 297-303 |
artikel |
24 |
Quantitative scoring of progression in transplant glomerulopathy using digital pathology may be superior to Banff cg scoring
|
Kikić, Željko |
|
|
103 |
2 |
p. 365-377 |
artikel |
25 |
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy
|
Barratt, Jonathan |
|
|
103 |
2 |
p. 391-402 |
artikel |
26 |
Subscription Information
|
|
|
|
103 |
2 |
p. A2 |
artikel |
27 |
Table of Contents
|
|
|
|
103 |
2 |
p. A3, A5, A7, A8 |
artikel |
28 |
Taking the A(llorecognition) train: connecting passenger T cells to DSA
|
Perkins, Griffith B. |
|
|
103 |
2 |
p. 246-248 |
artikel |
29 |
Targeting inflammation to treat diabetic kidney disease: the road to 2030
|
Rayego-Mateos, Sandra |
|
|
103 |
2 |
p. 282-296 |
artikel |
30 |
The authors reply
|
Caza, Tiffany N. |
|
|
103 |
2 |
p. 427 |
artikel |
31 |
The authors reply
|
Groen in ’t Woud, Sander |
|
|
103 |
2 |
p. 428 |
artikel |
32 |
The Case | A benign reason behind a malignant finding
|
Bharati, Joyita |
|
|
103 |
2 |
p. 433-434 |
artikel |
33 |
The oxidative phosphorylation inhibitor IM156 suppresses B-cell activation by regulating mitochondrial membrane potential and contributes to the mitigation of systemic lupus erythematosus
|
Shim, Joo Sung |
|
|
103 |
2 |
p. 343-356 |
artikel |
34 |
The pathologic spectrum of adenovirus nephritis in the kidney allograft
|
Jagannathan, Geetha |
|
|
103 |
2 |
p. 378-390 |
artikel |
35 |
TIPS to decide whether to prescribe aspirin for the primary prevention of cardiovascular events in chronic kidney disease
|
Roshanov, Pavel S. |
|
|
103 |
2 |
p. 261-263 |
artikel |
36 |
Toward a bona fide animal model of PLA2R1-associated membranous nephropathy: one step forward
|
Bihl, Franck |
|
|
103 |
2 |
p. 251-253 |
artikel |
37 |
Unique problems for the design of the first trials of transplanting porcine kidneys into humans
|
Reese, Peter P. |
|
|
103 |
2 |
p. 239-242 |
artikel |
38 |
Uromodulin and CKD: insight into variant pathogenicity
|
Franceschini, Nora |
|
|
103 |
2 |
p. 248-250 |
artikel |